Literature DB >> 16545806

Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model.

Heber Siachoque1, Fanny Guzman, Javier Burgos, Manuel Elkin Patarroyo, Jorge Enrique Gomez Marin.   

Abstract

Vaccines are promising for the control of toxoplasmosis. Here, we evaluated the immunogenicity of 17 peptides derived from SAG1 surface protein of Toxoplasma gondii in CH3 mice. Only 8 of 16 peptides induced specific antibodies. After a lethal challenge, only the vaccination with 4 of 17 peptides that were from the carboxy terminal end of the protein conferred significant survival. Our work shows that vaccination with peptides from the carboxy-terminal positions of SAG1 major surface protein of Toxoplasma protects mice against a lethal challenge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545806     DOI: 10.1016/j.exppara.2006.02.005

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  14 in total

Review 1.  Review on the identification and role of Toxoplasma gondii antigenic epitopes.

Authors:  Yanhua Wang; Guangxiang Wang; Jianping Cai; Hong Yin
Journal:  Parasitol Res       Date:  2015-11-19       Impact factor: 2.289

2.  A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo.

Authors:  Benjamin J Daniel; Srilakshmi Pandeswara; Michael J Brumlik; Aijie Liu; Suzanne R Thibodeaux; Sara M Ludwig; Xiuhua Sun; Tyler J Curiel
Journal:  J Immunol Methods       Date:  2010-02-08       Impact factor: 2.303

3.  Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis.

Authors:  Elizabeth Torres-Morales; Laura Taborda; Nestor Cardona; Alejandra De-la-Torre; Juan Carlos Sepulveda-Arias; Manuel Alfonso Patarroyo; Jorge Enrique Gomez-Marin
Journal:  Med Microbiol Immunol       Date:  2014-05-11       Impact factor: 3.402

4.  Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice.

Authors:  Shan Liu; Lin Shi; Yan-bin Cheng; Gui-xiang Fan; Hui-xun Ren; Yu-kang Yuan
Journal:  Parasitol Res       Date:  2009-03-14       Impact factor: 2.289

5.  Immunogenicity and protection efficacy of enhanced fitness recombinant Salmonella Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis.

Authors:  Fei-Kean Loh; Sheila Nathan; Sek-Chuen Chow; Chee-Mun Fang
Journal:  Pathog Glob Health       Date:  2021-02-01       Impact factor: 2.894

Review 6.  Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis.

Authors:  Henryka Dlugonska
Journal:  J Biomed Biotechnol       Date:  2008

7.  SAG4 DNA and Peptide Vaccination Provides Partial Protection against T. gondii Infection in BALB/c Mice.

Authors:  Jian Zhou; Lin Wang
Journal:  Front Microbiol       Date:  2017-09-07       Impact factor: 5.640

8.  Screening and identification of novel B cell epitopes of Toxoplasma gondii SAG1.

Authors:  Yanhua Wang; Guangxiang Wang; Delin Zhang; Hong Yin; Meng Wang
Journal:  Parasit Vectors       Date:  2013-04-30       Impact factor: 3.876

9.  Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.

Authors:  Min Meng; Shenyi He; Guanghui Zhao; Yang Bai; Huaiyu Zhou; Hua Cong; Gang Lu; Qunli Zhao; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2012-11-26       Impact factor: 3.876

Review 10.  Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii.

Authors:  Yanhua Wang; Hong Yin
Journal:  Parasit Vectors       Date:  2014-04-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.